Cervical cancer screening guidelines: An update.
Journal
JAAPA : official journal of the American Academy of Physician Assistants
ISSN: 1547-1896
Titre abrégé: JAAPA
Pays: United States
ID NLM: 9513102
Informations de publication
Date de publication:
01 Sep 2021
01 Sep 2021
Historique:
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
25
11
2021
Statut:
ppublish
Résumé
Cervical cancer screening practices in the United States have been inefficient, with variable screening rates. Some women are screened too frequently, overmanaged, lost to follow-up, or are at risk and should be screened but are not. Timely screening, identification, and management of abnormal cervical cells is vital in order to prevent progression to cervical cancer. Educating, counseling, screening, and offering the human papillomavirus vaccine continue to be the primary methods of cervical cancer prevention practices. Guidelines and primary screening methods have been updated because of supporting evidence, and clinicians must stay up-to-date in order to provide effective patient care.
Identifiants
pubmed: 34448772
doi: 10.1097/01.JAA.0000769656.60157.95
pii: 01720610-202109000-00003
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Pagination
21-24Informations de copyright
Copyright © 2021 American Academy of Physician Assistants.
Références
Centers for Disease Control and Prevention. Cervical cancer statistics. www.cdc.gov/cancer/cervical/statistics . Accessed June 29, 2021.
Centers for Disease Control and Prevention. Basic information about cervical cancer. www.cdc.gov/cancer/cervical/basic_info/index.htm . Accessed June 29, 2021.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet . 2019;393(10167):169–182.
National Cancer Institute. Cancer stat facts: cervical cancer. https://seer.cancer.gov/statfacts/html/cervix.html . Accessed May 19, 2021.
Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther . 2017;4(12):1795–1811.
National Cancer Institute. HPV and Pap testing. www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet . Accessed May 19, 2021.
Centers for Disease Control and Prevention. Basic information about cervical cancer. www.cdc.gov/cancer/cervical/basic_info/index.htm . Accessed May 19, 2021.
Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin . 2020;70(5):321–346.
Henderson JT, Saraiya M, Martinez G, et al. Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med . 2013;56(1):25–29.
Fields MM. New cervical cancer screening guidelines: was the annual Pap too much of a good thing. J Adv Pract Oncol . 2013;4(1):59–64.
Saslow D, Solomon D, Lawson HW, et al; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol . 2012;137(4):516–542.
Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis . 2020;24(2):102–131.
Rerucha CM, Caro RJ, Wheeler VL. Cervical cancer screening. Am Fam Physician . 2018;97(7):441–448.
Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA . 2018;320(7):674–686.
American College of Obstetricians and Gynecologists. Frequently asked questions. Cervical cancer screening. www.acog.org/Patients/FAQs/Cervical-Cancer-Screening . Accessed May 19, 2021.
White MC, Shoemaker ML, Benard VB. Cervical cancer screening and incidence by age: unmet needs near and after the stopping age for screening. Am J Prev Med . 2017;53(3):392–395.
American Cancer Society. Key statistics for cervical cancer. www.cancer.org/cancer/cervical-cancer/about/key-statistics.html . Accessed May 19, 2021.
Centers for Disease Control and Prevention. Some older women are not getting recommended cervical cancer screenings. www.cdc.gov/cancer/dcpc/research/articles/older-women-cervical-cancer-screenings.htm . Accessed May 19, 2021.
American College of Obstetricians and Gynecologists. Abnormal cervical cancer screening test results. www.acog.org/Patients/FAQs/Abnormal-Cervical-Cancer-Screening-Test-Results . Accessed May 19, 2021.
American Society of Colposcopy and Clinical Pathology. Management guidelines. www.asccp.org/management-guidelines . Accessed May 19, 2021.
American Cancer Society. Tests for cervical cancer. www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/how-diagnosed.html . Accessed May 19, 2021.
US Food and Drug Administration. FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old . Accessed May 19, 2021.
Memorial Sloan Kettering Cancer Center. Prevention, causes, and risk factors for head and neck cancer. www.mskcc.org/cancer-care/types/head-neck/risk-prevention-screening . Accessed May 19, 2021.
Centers for Disease Control and Prevention. Evidence to recommendations for HPV vaccination of adults, ages 27 through 45 years. www.cdc.gov/vaccines/acip/recs/grade/HPV-adults-etr.html . Accessed May 19, 2021.
National Cancer Institute. Next steps after an abnormal screening test: understanding HPV and Pap test results. www.cancer.gov/types/cervical/understanding-cervical-changes . Accessed May 19, 2021.
Boardman LA, Robison K. Screening adolescents and young women. Obstet Gynecol Clin North Am . 2013;40(2):257–268.